Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Oestrogen receptors and the response to endocrine therapy in advanced breast cancer

Abstract

The relationship between oestrogen-receptor protein (ER) content of the tumour and the response to endocrine therapy was determined in 119 patients, in a collaborative prospective study. Twenty-eight of the 80 patients with measurable ER responded to treatment according to UICC criteria, compared with only 3/39 without ER. It was found that site of biopsy did not influence the result, but tumour content of the tissue sample was significantly related to the presence of receptors. The organizational problems of such a study are discussed.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Authors

Additional information

A project sponsored by the British Breast Grotup.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roberts, M., Rubens, R., King, R. et al. Oestrogen receptors and the response to endocrine therapy in advanced breast cancer. Br J Cancer 38, 431–436 (1978). https://doi.org/10.1038/bjc.1978.225

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1978.225

This article is cited by

Search

Quick links